Search research articles
Contact Us
Filters
Showing results (31-40 of 166) with videos related to
Page
of 17
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 13, 2011
Systematic review of therapy for men with overactive bladder
Christopher Chapple
Arab Journal of Urology
|
November 19, 2015
Collaboration and education
Christopher Chapple
Neurourology and Urodynamics
|
March 14, 2007
The new publication policy of Neurourology and Urodynamics
Christopher Chapple
Current Opinion in Urology
|
June 2, 2009
Editorial comment. Female urology
Christopher Chapple
Neurourology and Urodynamics
|
July 22, 2014
Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder
Christopher Chapple
BJU International
|
June 7, 2014
Mirabegron the first β3-adrenoceptor agonist for overactive bladder (OAB): a summary of the phase III studies
Christopher Chapple
F1000Research
|
May 19, 2020
Recent Advances in treatment of urethral stricture disease in men
Naside Mangir, Christopher Chapple
European Urology
|
February 7, 2006
Botulinum toxin--new mechanisms, new therapeutic directions?
Christopher Chapple, Anand Patel
Current Urology Reports
|
August 26, 2006
Acute urinary retention: who is at risk and how best to manage it?
Anand Patel, Christopher Chapple
Current Opinion in Urology
|
September 10, 2010
Management of anterior urethral stricture: an evidence-based approach
Altaf Mangera, Christopher Chapple
Page
of 17
Search research articles
Search
Showing results (31-40 of 166) with videos related to
Sort By:
Page
of 17
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
October 13, 2011
Systematic review of therapy for men with overactive bladder
Christopher Chapple
Arab Journal of Urology
|
November 19, 2015
Collaboration and education
Christopher Chapple
Neurourology and Urodynamics
|
March 14, 2007
The new publication policy of Neurourology and Urodynamics
Christopher Chapple
Current Opinion in Urology
|
June 2, 2009
Editorial comment. Female urology
Christopher Chapple
Neurourology and Urodynamics
|
July 22, 2014
Best practice in the use of onabotulinumtoxinA (BOTOX®) to optimize patient outcomes in overactive bladder
Christopher Chapple
BJU International
|
June 7, 2014
Mirabegron the first β3-adrenoceptor agonist for overactive bladder (OAB): a summary of the phase III studies
Christopher Chapple
F1000Research
|
May 19, 2020
Recent Advances in treatment of urethral stricture disease in men
Naside Mangir, Christopher Chapple
European Urology
|
February 7, 2006
Botulinum toxin--new mechanisms, new therapeutic directions?
Christopher Chapple, Anand Patel
Current Urology Reports
|
August 26, 2006
Acute urinary retention: who is at risk and how best to manage it?
Anand Patel, Christopher Chapple
Current Opinion in Urology
|
September 10, 2010
Management of anterior urethral stricture: an evidence-based approach
Altaf Mangera, Christopher Chapple
Page
of 17